Stock 688166 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company BrightGene Bio-Medical Technology Co., Ltd.

Equities

688166

CNE100003PR1

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 20/05/2024 BST 		5-day change 1st Jan Change
38.4 CNY +1.56% Intraday chart for BrightGene Bio-Medical Technology Co., Ltd. +10.12% +9.71%
05-07 China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% MT
05-07 BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% MT

Business Summary

BrightGene Bio-Medical Technology Co Ltd is a China-based company mainly engaged in the research, development and production of generic drugs and original new drugs. The Company's main products include antifungal active pharmaceutical ingredients (APIs), antiviral APIs, immunosuppressive APIs, and other APIs and preparations. The Company's generic drugs mainly include entecavir, caspofungin, micafungin, posaconazole, everolimus and fondaparinux sodium. The Company mainly conducts its businesses in domestic and overseas markets.

Number of employees: 1,155

Sales per Business

CNY in Million2022Weight2023Weight Delta
Product
86.8 %
878 86.3 % 1,023 86.8 % +16.63%
Technology
6.4 %
84 8.3 % 76 6.4 % -10.17%
Equity Share
5.2 %
51 5.1 % 62 5.2 % +20.46%
Other Business
1.6 %
4 0.4 % 18 1.6 % +353.84%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,017 100.0 % 1,180 100.0 % +15.94%

Managers

Managers TitleAgeSince
Jian Dong Yuan CEO
 Chief Executive Officer 54 25/10/01
Yuan Lai Zou DFI
 Director of Finance/CFO 53 31/12/10
Fan Hang BRD
 Director/Board Member 38 31/12/05
Yang Qing Huang BRD
 Director/Board Member 43 31/12/08
Jing Yan Song IRC
 Investor Relations Contact 28 30/09/21
Nan Ding SEC
 Corporate Secretary 33 19/04/21
Kai Li PRN
 Corporate Officer/Principal 48 31/12/06

Members of the board

Members of the board TitleAgeSince
Jian Dong Yuan CEO
 Chief Executive Officer 54 25/10/01
Simon Lü BRD
 Director/Board Member 56 12/05/17
Kai Li PRN
 Corporate Officer/Principal 48 31/12/06
Yang Qing Huang BRD
 Director/Board Member 43 31/12/08
Li Zhang BRD
 Director/Board Member 42 28/02/09
Ruyi He BRD
 Director/Board Member 63 17/09/23
Wei Cha BRD
 Director/Board Member 54 31/12/14
Ying Hua Wu BRD
 Director/Board Member 54 17/09/23
Dong Dong Xu BRD
 Director/Board Member - 17/09/23
Zi Jun Zhang BRD
 Director/Board Member 27 30/04/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 422,466,561 203,822,261 ( 48.25 %) 0 48.25 %

Shareholders

NameEquities%Valuation
Jian Dong Yuan
27.69 %
113,535,123 27.69 % 486 M ¥
Suzhou Borui Xinwen Management Consultancy LP
6.537 %
26,801,844 6.537 % 115 M ¥
Wei Fang Zhong
5.498 %
22,543,669 5.498 % 96 M ¥
SDIC Innovation Investment Management Co. Ltd.
4.540 %
18,612,863 4.540 % 80 M ¥
Hongshan
3.355 %
13,757,411 3.355 % 59 M ¥
Huatai Zijin Investment Co., Ltd.
1.747 %
7,162,037 1.747 % 31 M ¥
Suzhou Gaoquan Venture Investment LP
1.410 %
5,780,426 1.410 % 25 M ¥
Hangzhou Mingjia Phase I Equity Investment Partnership LP
1.292 %
5,296,474 1.292 % 23 M ¥
Jiangsu Jingfeng Zhengde Venture Capital Investment Co. Ltd.
1.257 %
5,154,453 1.257 % 22 M ¥
Wanjia Asset Management Co., Ltd.
1.234 %
5,057,573 1.234 % 22 M ¥

Company contact information

BrightGene Bio-Medical Technology Co., Ltd.

Suzhou Industrial Park Building C25

215123, Suzhou

+

http://www.bright-gene.com
address BrightGene Bio-Medical Technology Co., Ltd.(688166)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. Stock BrightGene Bio-Medical Technology Co., Ltd.
+9.71% 2.21B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+37.78% 705B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.82% 583B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.51% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.94% 332B
ABBVIE INC. Stock AbbVie Inc.
+5.14% 291B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.64% 238B
ROCHE HOLDING AG Stock Roche Holding AG
-4.13% 210B
NOVARTIS AG Stock Novartis AG
+10.63% 209B
AMGEN INC. Stock Amgen Inc.
+9.32% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688166 Stock
  4. Company BrightGene Bio-Medical Technology Co., Ltd.